(S)-METHYL 4,5,6,7-TETRAHYDRO-3H-IMIDAZO[4,5-C]PYRIDINE-6-CARBOXYLATE 2HCL, 95.0%, 5g

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 1.00 µm, 1 Piece(s)

1-methyl-1H-imidazo[1,2-b]pyrazole-7-carboxylic acid, 95.0%, 10g

4'-Chloro-2,2,2,3'-tetrafluoroacetophenone, 97.0%, 1g

2-(2-(2-(4-Nitrophenoxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate, 98%, 250mg

(2-Methoxy-4-nitrophenyl)boronic acid, 95+%, 1g

Molybdenum foil 99.95% 0.1 x 100 x 100 mm 1 pc

4-{4-[Bis(4-fluorophenyl)methyl]piperazin-1-yl}phenylamine, 1g

(5-Fluoro-2-(N-methylsulfamoyl)phenyl)boronic acid, 95.0%, 5g

2-Cyano-6-hydroxybenzothiazole, 97.0%, 10g

(E)-2-((1-Acetyl-3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)-N-methylbenzamide (Axitinib Impurity), 97%, 50mg

5,7-Dimethyl-2,3-dihydro-1H-inden-1-one, 95.0%, 250mg

2-(2,3-Dichlorobenzoyl)pyridine, 97.0%, 1g